title: Two better than one.
authors.forename: Ruth
authors.initials: R
authors.lastname: SoRelle
mesh_terms: D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D058544:Class Ib Phosphatidylinositol 3-Kinase; D003072:Cognition Disorders / Q000209:etiology*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000008:administration & dosage / Q000627:therapeutic use*; D000077545:Eplerenone; D005343:Fibrinolytic Agents; D006333:Heart Failure / Q000201:enzymology* / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000523:psychology*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000503:physiopathology; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000172:deficiency / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D015425:Myocardial Reperfusion; D019869:Phosphatidylinositol 3-Kinases / Q000172:deficiency / Q000502:physiology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D013148:Spironolactone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D058544:Class Ib Phosphatidylinositol 3-Kinase; D004656:Enalapril; D000077545:Eplerenone; D005343:Fibrinolytic Agents; D007527:Isoenzymes; D000451:Mineralocorticoid Receptor Antagonists; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011943:Receptors, Adrenergic, beta; D013148:Spironolactone; C546760:PIK3CG protein, human; C546764:Pik3cg protein, mouse